Novo Nordisk (NVO) stock rises, and Agios Pharma (AGIO) stock drops as the Danish company posts a late-stage trial win for a ...
The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...
Experts from AMCP emphasize the importance of drug-adjacent early detection tests and screening ability to improve patient ...
Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...
Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced positive ...
Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the presentation of updated data from its Phase 1 trial of ...
Patients with RAS G12D non-small cell lung cancer remain a population with a significant unmet medical need for targeted therapeutic options,” said Jonathan Riess M.D., medical director of thoracic ...
Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer ...
This year, consider not only the gardening gear and plants you bring home, but also whether they’re made of, contained in or ...
A federal judge checks in on orders for better attorney/client access and clear information at Alligator Alcatraz immigration ...
This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...
Poachers once held a huge advantage over wildlife rangers. They moved quietly and struck under the cover of darkness while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results